Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults

P Caron, S Grunenwald, L Persani… - Reviews in Endocrine …, 2022 - Springer
Levothyroxine (LT4) is a safe, effective means of hormone replacement therapy for
hypothyroidism. Here, we review the pharmaceutical, pathophysiological and behavioural …

Pathophysiological relevance of deiodinase polymorphism

AC Bianco, BS Kim - Current Opinion in Endocrinology, Diabetes …, 2018 - journals.lww.com
The finding of deiodinase polymorphisms that can diminish thyroid hormone signaling
and/or disrupt normal cellular function opens the door to customized treatment of …

[HTML][HTML] Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

R Hoermann, JEM Midgley, R Larisch… - Drugs in context, 2019 - ncbi.nlm.nih.gov
Levothyroxine (LT4) therapy has a long history, a well-defined pharmacological profile and a
favourable safety record in the alleviation of hypothyroidism. However, questions remain in …

[HTML][HTML] Iodothyronine deiodinases and reduced sensitivity to thyroid hormones

RM Paragliola, A Corsello, P Concolino… - Frontiers in Bioscience …, 2020 - imrpress.com
Iodothyronine deiodinases are selenoproteins that regulate thyroid hormone metabolism. Of
the three types of deiodinases, type 2 is the major regulator of intracellular triiodothyronine …

Integrative analysis of histomorphology, transcriptome and whole genome resequencing identified DIO2 gene as a crucial gene for the protuberant knob located on …

Y Deng, S Hu, C Luo, Q Ouyang, L Li, J Ma, Z Lin… - Bmc Genomics, 2021 - Springer
Background During domestication, remarkable changes in behavior, morphology,
physiology and production performance have taken place in farm animals. As one of the …

Optimizing levothyroxine replacement: A precision dosage model for post-thyroidectomy patients

G Yang, J Pu, S Zhu, Y Shi, Y Yang, J Mao… - … Journal of General …, 2024 - Taylor & Francis
Background Thyroidectomy is commonly performed for benign or malignant thyroid tumors,
often resulting in hypothyroidism. Levothyroxine (LT4) supplementation is crucial to maintain …

Ionic Levothyroxine Formulations: Synthesis, Bioavailability, and Cytotoxicity Studies

A Barreira, AFM Santos, M Dionísio, AR Jesus… - International Journal of …, 2023 - mdpi.com
Thyroid diseases affect a considerable portion of the population, with hypothyroidism being
one of the most commonly reported thyroid diseases. Levothyroxine (T4) is clinically used to …

Type 2 deiodinase p. Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery

N Benenati, A Bufano, S Cantara, C Ricci… - Scientific Reports, 2022 - nature.com
A single nucleotide polymorphism in the Type 2 deiodinase (DIO2) gene (p. Thr92Ala) was
found to be associated with hypertension, type 2 diabetes mellitus (T2DM), insulin …

SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients

R AlEjielat, A Khaleel, YS Batarseh… - BMC Endocrine …, 2023 - Springer
Background and purpose Primary hypothyroidism due to abnormality in the thyroid gland is
the most common endocrine disease The recommended starting dose of levothyroxine …

Association of pharmacogenomic, clinical and behavioural factors with oral levothyroxine (LT-4) dose of hypothyroid patients in Sri Lanka: a matched case control …

SS Dalugodage, G Bowatte, C Antonypillai… - BMC Medical …, 2024 - Springer
Background Hypothyroidism is a common endocrine disorder that exerts a substantial
influence on people all over the world. Levothyroxine (LT-4) is the drug of choice for the …